Cardio Diagnostics Holdings, Inc. key statistics and ratios

In fiscal 2025, Cardio Diagnostics Holdings, Inc. had return on equity of -78.6%, an operating margin of -43737.5%, debt equal to 0.0% of equity and a current ratio of 9.79. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cardio Diagnostics Holdings, Inc.: financial ratios, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Operating margin	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%
Net margin	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%
Free-cash-flow margin	—	—	<−999%	<−999%	<−999%	<−999%
Return on equity	−58.1%	−173.6%	—	−134.0%	−78.6%	−89.9%
Return on assets	−56.3%	−126.8%	−156.4%	−111.2%	−70.7%	−82.5%
Asset turnover	0.00	0.00	0.00	0.00	0.00	0.00
Current ratio	6.46	3.02	3.29	13.92	9.79	17.15
Debt to equity	—	0.0%	0.0%	0.0%	0.0%	0.0%
Interest cover (operating income ÷ interest)	—	—	n/m	n/m	n/m	n/m
R&D as % of revenue	>999%	>999%	850.8%	653.4%	>999%	>999%
Capital spending as % of revenue	—	—	>999%	615.5%	>999%	>999%

US$ thousands unless shown otherwise. Fiscal quarters.

Cardio Diagnostics Holdings, Inc.: financial ratios, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Operating margin	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%
Net margin	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%
Free-cash-flow margin	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%	<−999%
Current ratio	8.51	13.92	19.49	23.55	17.39	9.79	15.76	17.15
R&D as % of revenue	79.7%	>999%	>999%	>999%	>999%	>999%	>999%	>999%
SG&A as % of revenue	>999%	—	—	>999%	>999%	—	—	—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · June 30, 2026

What it owns · $8m

Short-term assets $6mLonger-term assets $2m

What it owes, and who funded it · $8m

Short-term liabilities $0mLonger-term liabilities $0mShareholders' equity $7m

Short-term assets cover short-term liabilities $6m of assets due within a year against $359,197 of liabilities due within a year.
Short-term assets cover long-term liabilities $6m short-term assets against $140,583 of longer-dated liabilities.
More cash than debt Cash or debt not separately reported. Not assessable.
Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
Operating profit covers interest at least five times over Operating income of −$6m against $12,299 of interest.

From Cardio Diagnostics Holdings, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: CDIO vs CUPR CDIO vs HSCS CDIO vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cardio Diagnostics Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardio Diagnostics Holdings, Inc.